| TKO |
Report |
Diluted EPS |
BEAT |
pred ~$1.82 vs. cons $1.72 |
MEDIUM |
| TKO |
Report |
Revenue |
BEAT |
pred ~$1.76B vs. cons $1.54B |
HIGH |
| TKO |
Report |
Adjusted EBITDA |
BEAT |
pred ~$690M vs. cons $660M |
MEDIUM |
| TKO |
Guide |
Full-year revenue guidance |
UNCHANGED |
guide ~$5.725B vs. cons $5.725B (FY2026) |
HIGH |
| TKO |
Guide |
Full-year Adjusted EBITDA guidance |
UNCHANGED |
guide ~$2.265B vs. cons $2.265B (FY2026) |
HIGH |
| TKO |
Guide |
UFC Freedom 250 loss commentary |
UNCHANGED |
guide ~($30M) vs. cons ~($30M) (2Q2026) |
HIGH |
| TKO |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.8% |
— |
MEDIUM |
| TKO |
Return |
5-day cumulative residual |
+1.5% (FADE) |
A WWE- and World Cup-led quarterly beat should produce an initial positive reaction, but unchanged FY2026 revenue and Adjusted EBITDA guide (~$5.725B and ~$2.265B) implies limited out-period estimate upside after the quarter; investors will also look through the known ~($30M) Freedom 250 drag and event-timing benefits. |
MEDIUM |